> top > docs > PMC:7205724 > spans > 18129-18324 > annotations

PMC:7205724 / 18129-18324 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
634 173-181 Species denotes patients Tax:9606
637 187-194 Disease denotes COVID19 MESH:C000657245

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T137 12-17 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T138 94-97 Body_part denotes IgG http://purl.org/sig/ont/fma/fma62872
T139 102-105 Body_part denotes IgM http://purl.org/sig/ont/fma/fma62873

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T20 12-17 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T134 187-194 Disease denotes COVID19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T226 125-127 http://purl.obolibrary.org/obo/CLO_0008192 denotes NP
T227 131-133 http://purl.obolibrary.org/obo/CLO_0001527 denotes 94
T228 163-165 http://purl.obolibrary.org/obo/CLO_0001527 denotes 94

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T159 125-127 Chemical denotes NP http://purl.obolibrary.org/obo/CHEBI_50803|http://purl.obolibrary.org/obo/CHEBI_53793|http://purl.obolibrary.org/obo/CHEBI_73425

LitCovid-sample-PD-IDO

Id Subject Object Predicate Lexical cue
T79 58-65 http://purl.obolibrary.org/obo/OGMS_0000020 denotes symptom

LitCovid-sample-PD-NCBITaxon

Id Subject Object Predicate Lexical cue ncbi_taxonomy_id
T180 187-194 Species denotes COVID19 NCBItxid:2697049

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T146 0-195 Sentence denotes Analysis of serum samples collected 14 or more days after symptom onset revealed detection of IgG and IgM antibodies against NP in 94% and 88% and RBD in 100% and 94% among patients with COVID19.

LitCovid-sample-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T20 12-17 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
634 173-181 Species denotes patients Tax:9606
637 187-194 Disease denotes COVID19 MESH:C000657245

LitCovid-sample-UniProt

Id Subject Object Predicate Lexical cue uniprot_id
T1980 147-150 Protein denotes RBD https://www.uniprot.org/uniprot/Q63492|https://www.uniprot.org/uniprot/Q63491|https://www.uniprot.org/uniprot/Q62815|https://www.uniprot.org/uniprot/Q62691|https://www.uniprot.org/uniprot/Q01542|https://www.uniprot.org/uniprot/P27732|https://www.uniprot.org/uniprot/O09024|https://www.uniprot.org/uniprot/O09023|https://www.uniprot.org/uniprot/O09022

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T76985 0-8 NN denotes Analysis
T6758 9-11 IN denotes of
T88720 12-17 NN denotes serum
T73739 18-25 NNS denotes samples
T20072 26-35 VBD denotes collected
T30704 36-38 CD denotes 14
T66398 39-41 CC denotes or
T43796 42-46 JJR denotes more
T64515 47-51 NNS denotes days
T88119 52-57 IN denotes after
T33297 58-65 NN denotes symptom
T78997 66-71 NN denotes onset
T69102 72-80 VBD denotes revealed
T51393 81-90 NN denotes detection
T49412 91-93 IN denotes of
T86080 94-97 NN denotes IgG
T42365 98-101 CC denotes and
T24248 102-105 NN denotes IgM
T84785 106-116 NNS denotes antibodies
T33598 117-124 IN denotes against
T65176 125-127 NN denotes NP
T29543 128-130 IN denotes in
T67075 131-133 CD denotes 94
T4274 133-134 NN denotes %
T73088 135-138 CC denotes and
T74097 139-141 CD denotes 88
T71868 141-142 NN denotes %
T54079 143-146 CC denotes and
T73098 147-150 NN denotes RBD
T69539 151-153 IN denotes in
T87988 154-157 CD denotes 100
T78691 157-158 NN denotes %
T18580 159-162 CC denotes and
T46489 163-165 CD denotes 94
T64615 165-166 NN denotes %
T60810 167-172 IN denotes among
T38563 173-181 NNS denotes patients
T93829 182-186 IN denotes with
T24980 187-194 NN denotes COVID19
R98284 T76985 T6758 arg1Of Analysis,of
R72949 T73739 T6758 arg2Of samples,of
R94093 T73739 T88720 arg1Of samples,serum
R64474 T76985 T20072 arg1Of Analysis,collected
R79737 T64515 T20072 arg2Of days,collected
R31087 T64515 T30704 arg1Of days,14
R58487 T30704 T66398 arg1Of 14,or
R48701 T30704 T43796 arg1Of 14,more
R91116 T20072 T88119 arg1Of collected,after
R29180 T69102 T88119 arg2Of revealed,after
R61094 T78997 T33297 arg1Of onset,symptom
R30751 T78997 T69102 arg1Of onset,revealed
R85646 T51393 T69102 arg2Of detection,revealed
R94930 T51393 T49412 arg1Of detection,of
R15007 T84785 T49412 arg2Of antibodies,of
R35220 T84785 T86080 arg1Of antibodies,IgG
R17029 T86080 T42365 arg1Of IgG,and
R36223 T24248 T42365 arg2Of IgM,and
R4871 T84785 T24248 arg1Of antibodies,IgM
R37373 T51393 T33598 arg1Of detection,against
R80609 T65176 T33598 arg2Of NP,against
R29116 T51393 T29543 arg1Of detection,in
R74727 T54079 T29543 arg2Of and,in
R31620 T4274 T67075 arg1Of %,94
R41074 T71868 T4274 arg1Of %,%
R32415 T4274 T73088 arg1Of %,and
R53047 T74097 T73088 arg2Of 88,and
R60224 T71868 T74097 arg1Of %,88
R30825 T71868 T54079 arg1Of %,and
R92508 T73098 T54079 arg2Of RBD,and
R99739 T54079 T69539 arg1Of and,in
R9744 T64615 T69539 arg2Of %,in
R73124 T78691 T87988 arg1Of %,100
R67370 T64615 T78691 arg1Of %,%
R15728 T78691 T18580 arg1Of %,and
R74845 T46489 T18580 arg2Of 94,and
R42305 T64615 T46489 arg1Of %,94
R38001 T51393 T60810 arg1Of detection,among
R89986 T38563 T60810 arg2Of patients,among
R54593 T38563 T93829 arg1Of patients,with
R6445 T24980 T93829 arg2Of COVID19,with

LitCovid-sample-PD-FMA

Id Subject Object Predicate Lexical cue fma_id
T137 12-17 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T138 94-97 Body_part denotes IgG http://purl.org/sig/ont/fma/fma62872
T139 102-105 Body_part denotes IgM http://purl.org/sig/ont/fma/fma62873

LitCovid-sample-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T129 187-194 Disease denotes COVID19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T146 0-195 Sentence denotes Analysis of serum samples collected 14 or more days after symptom onset revealed detection of IgG and IgM antibodies against NP in 94% and 88% and RBD in 100% and 94% among patients with COVID19.